Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
522.68
-6.56 (-1.24%)
At close: Jun 16, 2025, 4:00 PM
522.08
-0.60 (-0.11%)
After-hours: Jun 16, 2025, 7:55 PM EDT
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of $55.23 billion as of June 16, 2025. Its market cap has decreased by -48.14% in one year.
Market Cap
55.23B
Enterprise Value
40.31B
1-Year Change
-48.14%
Ranking
Category
Stock Price
$522.68
Market Cap Chart
Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $55.23B, an increase of 21,816.37%. That is a compound annual growth rate of 22.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 13, 2025 | 57.14B | -27.00% |
Dec 31, 2024 | 78.28B | -18.19% |
Dec 29, 2023 | 95.69B | 21.78% |
Dec 30, 2022 | 78.57B | 15.69% |
Dec 31, 2021 | 67.92B | 31.74% |
Dec 31, 2020 | 51.55B | 25.04% |
Dec 31, 2019 | 41.23B | 1.98% |
Dec 31, 2018 | 40.43B | 0.08% |
Dec 29, 2017 | 40.39B | 4.33% |
Dec 30, 2016 | 38.72B | -31.47% |
Dec 31, 2015 | 56.49B | 35.45% |
Dec 31, 2014 | 41.71B | 52.42% |
Dec 31, 2013 | 27.36B | 65.66% |
Dec 31, 2012 | 16.52B | 221.91% |
Dec 30, 2011 | 5.13B | 89.94% |
Dec 31, 2010 | 2.70B | 38.80% |
Dec 31, 2009 | 1.95B | 33.11% |
Dec 31, 2008 | 1.46B | -8.46% |
Dec 31, 2007 | 1.60B | 38.55% |
Dec 29, 2006 | 1.15B | 29.12% |
Dec 30, 2005 | 893.00M | 73.94% |
Dec 31, 2004 | 513.40M | -36.89% |
Dec 31, 2003 | 813.50M | -0.20% |
Dec 31, 2002 | 815.10M | -33.81% |
Dec 31, 2001 | 1.23B | -5.01% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 735.57B |
Johnson & Johnson | 377.99B |
Novo Nordisk | 355.28B |
AbbVie | 337.52B |
UnitedHealth Group | 284.42B |
Abbott Laboratories | 235.96B |
Novartis AG | 234.52B |
AstraZeneca | 231.58B |